Nachrichten zur Meridian Bioscience Inc. Aktie

Loop-mediated Isothermal Amplification (LAMP) Market revenue to cross USD 180 Million by 2033, says Research Nester

Major Loop-mediated Isothermal Amplification (LAMP) Market players include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Nippon Gene…

Typhoid Antibody Testing Market Size, Outlook: Exploring the 6.55% CAGR and USD 12.36 Billion Projection by 2030

[222 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…

Global Enteric Disease Testing Market Report to 2027 - Players Include Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience and Quest Diagnostics

DUBLIN, Feb. 2, 2023 /PRNewswire/ -- The "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast…

Form 8-K MERIDIAN BIOSCIENCE INC For: Jan 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

XFRA : Deletion of Instruments from Boerse Frankfurt - 31.01.2023

The following instruments on Boerse Frankfurt do have their last trading day on 31.01.2023 Die folgenden Instrumente in Boerse Frankfurt haben…

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of…

XFRA : MR4: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION - US5895841014

Instrument ID [10141] (MR4 - US5895841014) suspended...…

DoubleVerify Holdings to Join S&P SmallCap 600

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in…

Meridian Bioscience Shares Up 7.7% on Takeover Set to Close Next Year

Meridian Bioscience Shares Up 7.7% on Takeover Set to Close Next Year...…

Meridian Bioscience gains after announcing Jan. 31 closing date for sale

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger

CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and…

Form 8-K MERIDIAN BIOSCIENCE INC For: Dec 12

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Meridian Bioscience (VIVO) Q4 Earnings Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do…

Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MERIDIAN BIOSCIENCE INC For: Nov 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MERIDIAN BIOSCIENCE INC For: Oct 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

dpa-AFX ProFeed